课题基金 / 基金详情

Role of TET Proteins in ES Cell Pluripotency and Function

Role of TET Proteins in ES Cell Pluripotency and Function
TET 蛋白在 ES 细胞多能性和功能中的作用
批准号:
8248719
负责人:
Anjana Rao
金额:
$35.68万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2016-01-31

项目摘要

项目成果

Anjana Rao的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):DNA的甲基化状态影响哺乳动物发育过程中的许多生物过程,并且已知在癌症中高度异常。我们最近发现TET蛋白TET1, TET2和TET3构成了一个新的1-酮戊二酸(1KG)和铁(II)依赖性双加氧酶家族,通过催化DNA中5-甲基胞嘧啶(5mC)氧化为5-羟基甲基胞嘧啶(5hmC)来改变DNA甲基化状态。Tet1、Tet2和5hmC在小鼠胚胎干细胞(ES)和诱导多能干细胞(iPS)中含量较高,提示5hmC在多能性中可能发挥作用。此外,5hmC水平和Tet表达/活性受到严格调控:5hmC存在于未分化的胚胎干细胞的基因组DNA中,但不存在于几种分化的细胞类型中,5hmC水平随着胚胎干细胞分化而降低。这些数据表明,通过TET蛋白和5hmC介导的DNA甲基化失调可能在胚胎干细胞的分化和功能中发挥作用。在此,我们拟分析Tet蛋白在小鼠ES和iPS细胞的基因表达、多能性和细胞命运规范中的生物学作用。在Aim 1中,我们将使用Tet缺失的ES细胞和小鼠,在体外和体内研究Tet蛋白在小鼠ES细胞分化和功能中的作用。在目标2中,我们将研究在将小鼠成纤维细胞重编程为iPS细胞时对Tet蛋白的需求。在Aim 3中,我们将通过转录谱鉴定ES细胞中Tet蛋白的靶基因,确定5hmC和Tet蛋白的基因组位置,并在基因组中以单碱基分辨率绘制5hmC的位置。该结果将为新的碱基5hmC和新发现的TET家族酶在ES和iPS细胞的多能性和干细胞功能中的作用提供新的见解。
英文摘要
DESCRIPTION (provided by applicant): The methylation status of DNA influences many biological processes during mammalian development, and is known to be highly aberrant in cancer. We recently discovered that the TET proteins TET1, TET2 and TET3 constitute a new family of 1-ketoglutarate (1KG)- and Fe(II)-dependent dioxygenases that alter DNA methylation status by catalysing the oxidation of 5-methylcytosine (5mC) to 5-hydroxy- methylcytosine (5hmC) in DNA. Tet1, Tet2 and 5hmC are present at high levels in mouse embryonic stem (ES) cells and induced pluripotent stem (iPS) cells, suggesting a potential role for 5hmC in pluripotency. Moreover, 5hmC levels and Tet expression/ activity are tightly regulated: 5hmC is present in genomic DNA of undifferentiated ES cells but not several differentiated cell types, and 5hmC levels diminish upon ES cell differentiation. Together these data suggest that dysregulation of DNA methylation via TET proteins and 5hmC may have a role in ES cell differentiation and function. Here we propose to analyze the biological roles of Tet proteins in gene expression, pluripotency and cell fate specification in mouse ES and iPS cells. In Aim 1, we will study the roles of Tet proteins in mouse ES cell differentiation and function in vitro and in vivo using Tet-deleted ES cells and mice. In Aim 2, we will examine the requirement for Tet proteins in reprogramming murine fibroblasts to iPS cells. In Aim 3, we will identify target genes for Tet proteins in ES cells by transcriptional profiling, defining the genomic locations of 5hmC and Tet proteins, and mapping the location of 5hmC at single- base resolution in the genome. The results should provide new insights into the role of the novel base, 5hmC, and the newly-discovered TET family of enzymes, in pluripotency and stem cell function in ES and iPS cells. PUBLIC HEALTH RELEVANCE: Role of TET proteins in ES cell pluripotency and function Narrative In addition to the four major bases in the DNA alphabet - A, C, G and T - there is also a very minor base known as 5-methylcytosine (5mC) that has a disproportionately crucial role. This base is produced from the major base cytosine (C) by attaching a methyl group to its "5" position. Interference with cytosine methylation can lead to a number of developmental abnormalities, genetic diseases and cancer. We recently identified a new class of proteins known as TET proteins that convert 5-methyl- cytosine to a variant known as 5-hydroxymethylcytosine (5hmC). TET proteins and 5-hmC are strongly expressed in mouse embryonic stem (ES) cells, and are induced to high levels when mouse fibroblasts are reprogrammed into induced pluripotent stem (iPS) cells. In this proposal we plan to investigate the role of TET1 and TET2 proteins in ES and iPS cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploring the potential of TET inhibition in cancer immunotherapy
Exploring the potential of TET inhibition in cancer immunotherapy
Exploring the potential of TET inhibition in cancer immunotherapy
Exploring the potential of TET inhibition in cancer immunotherapy
海外基金